Furthermore, results for western blot assays also showed that after overexpression of miR-125a, the expression level of mesenchymal marker N-cadherin was significantly downregulated, whereas a moderate elevation was observed in E-cadherin, which is a well-defined epithelial marker, indicating that miR-125a was a suppressor for EMT in NPC cells. The gene discussed is CDH2; the disease is nasopharyngeal carcinoma.